Summary & Overview
HCPCS E2508: Speech-Generating Device, Synthesized Speech, Spelling Access
HCPCS Level II code E2508 identifies a speech-generating device that produces synthesized speech and requires message formulation by spelling with activation through physical contact. This code captures a category of augmentative and alternative communication (AAC) equipment crucial for individuals with severe expressive communication impairments. Nationally, access to AAC devices affects functional independence, participation in education and employment, and long-term care needs.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage considerations and typical reimbursement contexts, including where these devices are commonly supplied and used. The publication presents benchmarks on utilization and payment patterns where available, summarizes relevant policy and coverage themes affecting AAC device access, and provides clinical context about the device functionality and typical service settings.
The content is organized to help clinical managers, billing professionals, and policy analysts understand coding implications, typical sites of service, and payer landscapes for E2508. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code E2508 describes a speech generating device with synthesized speech that requires message formulation by spelling and access by physical contact with the device. This device is designed to support individuals with complex communication needs who can compose messages via spelling and activate output through direct touch.
Service type: Augmentative and Alternative Communication (AAC) device provision and support
Typical site of service: Outpatient durable medical equipment setting, specialty clinics, schools, and community settings where AAC devices are provided and trained
Clinical & Coding Specifications
Clinical Context
A patient with severe expressive aphasia and limited speech output after a left hemispheric stroke is evaluated by a multidisciplinary team for augmentative and alternative communication (AAC). The patient is cognitively able to spell and use direct physical contact to operate a device but cannot produce intelligible natural speech. A speech-language pathologist conducts an AAC assessment, documents the need for a speech-generating device that produces synthesized speech and requires message formulation by spelling with physical contact access, and recommends device procurement under billing code E2508. The typical clinical workflow includes: referral from neurology or rehabilitation medicine; an SLP AAC evaluation documenting functional communication deficits, motor access method, and cognitive ability to use a spelling-based interface; a trial of device options in clinic; a written order and justification for E2508; device setup and personalization by an SLP or durable medical equipment (DME) vendor; training sessions with the patient and caregivers; follow-up visits for programming and adjustments; and documentation of continued medical necessity for replacement or upgrades. Typical sites of service are outpatient rehabilitation clinics, inpatient rehabilitation units, skilled nursing facilities, and home health settings where DME can be delivered and trained on-site. Payors involved commonly include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthCare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|